AU2002217808A1 - Inositol derivatives for increasing chloride secretion and inhibiting inflammation - Google Patents
Inositol derivatives for increasing chloride secretion and inhibiting inflammationInfo
- Publication number
- AU2002217808A1 AU2002217808A1 AU2002217808A AU1780802A AU2002217808A1 AU 2002217808 A1 AU2002217808 A1 AU 2002217808A1 AU 2002217808 A AU2002217808 A AU 2002217808A AU 1780802 A AU1780802 A AU 1780802A AU 2002217808 A1 AU2002217808 A1 AU 2002217808A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibiting inflammation
- chloride secretion
- inositol derivatives
- increasing chloride
- increasing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 150000004001 inositols Chemical class 0.000 title 1
- 230000028327 secretion Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65525—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a seven-(or more) membered ring
- C07F9/65527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25260300P | 2000-11-21 | 2000-11-21 | |
| US60252603 | 2000-11-21 | ||
| US60/252,603 | 2000-11-21 | ||
| PCT/US2001/043664 WO2002041831A2 (fr) | 2000-11-21 | 2001-11-21 | Derives d'inositol augmentant la secretion de chrolure et freinant l'inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002217808A1 true AU2002217808A1 (en) | 2002-06-03 |
Family
ID=22956721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002217808A Abandoned AU2002217808A1 (en) | 2000-11-21 | 2001-11-21 | Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7453006B2 (fr) |
| EP (1) | EP1345950A4 (fr) |
| JP (1) | JP2004518639A (fr) |
| AU (1) | AU2002217808A1 (fr) |
| CA (1) | CA2430190A1 (fr) |
| WO (1) | WO2002041831A2 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2828206B1 (fr) * | 2001-08-03 | 2004-09-24 | Centre Nat Rech Scient | Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire |
| WO2003024189A2 (fr) * | 2001-09-20 | 2003-03-27 | Inologic, Inc. | Procede de modulation de l'absorption des ions sodium dans les cellules epitheliales |
| WO2003092700A1 (fr) | 2002-04-29 | 2003-11-13 | Gmp Oxycell, Inc. | Inositol pyrophosphates et procede d'utilisation desdits composes |
| WO2004075906A1 (fr) * | 2003-02-26 | 2004-09-10 | Regenetiss Co., Ltd. | Agent anti-inflammatoire et matiere therapeutique anti-inflammatoire |
| US20060258626A1 (en) * | 2004-07-06 | 2006-11-16 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
| US20060106000A1 (en) * | 2004-07-06 | 2006-05-18 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
| US7745423B2 (en) * | 2004-07-06 | 2010-06-29 | NormOxys, Inc | Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
| DK1863495T3 (en) * | 2005-03-18 | 2015-04-20 | Normoxys Inc | CALCIUM AND SODIUM SALT OF MYO-INOSITOL 1.6: 2,3: 4,5 TRIPYROPHOSPHATE FOR CANCER TREATMENT |
| WO2007142510A1 (fr) * | 2006-06-09 | 2007-12-13 | Erasmus University Medical Center Rotterdam | Modulation du système immunitaire par des phospholipides d'inositol |
| US20080312138A1 (en) * | 2007-05-01 | 2008-12-18 | Claude Nicolau | Erythropoietin complementation or replacement |
| EP3023114A1 (fr) | 2009-10-08 | 2016-05-25 | SHL Group AB | Dispositifs d'administration de médicaments |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8605063D0 (sv) | 1986-11-26 | 1986-11-26 | Matti Siren | Derivatives of cyclohexane |
| FR2694936B1 (fr) | 1992-08-18 | 1994-11-25 | Bayer Pharma | Dérivés substitués du désoxy-myoinositol, procédé pour leur préparation et leur utilisation dans des médicaments. |
| SE503122C2 (sv) | 1993-11-22 | 1996-03-25 | Perstorp Ab | Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd |
| US5977078A (en) | 1996-09-20 | 1999-11-02 | The Regents Of The Univesity Of California | Inositol polyphosphate derivatives and methods of using same |
| JP2002524016A (ja) | 1996-09-20 | 2002-07-30 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | イノシトールポリホスフェート誘導体およびその使用方法 |
| US6221856B1 (en) * | 1999-02-03 | 2001-04-24 | Inologic, Inc. | Inositol derivatives for inhibiting superoxide anion production |
-
2001
- 2001-11-21 JP JP2002544012A patent/JP2004518639A/ja active Pending
- 2001-11-21 WO PCT/US2001/043664 patent/WO2002041831A2/fr active Application Filing
- 2001-11-21 US US10/432,340 patent/US7453006B2/en not_active Expired - Fee Related
- 2001-11-21 AU AU2002217808A patent/AU2002217808A1/en not_active Abandoned
- 2001-11-21 CA CA002430190A patent/CA2430190A1/fr not_active Abandoned
- 2001-11-21 EP EP01997275A patent/EP1345950A4/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004518639A (ja) | 2004-06-24 |
| US20040147487A1 (en) | 2004-07-29 |
| US7453006B2 (en) | 2008-11-18 |
| WO2002041831A2 (fr) | 2002-05-30 |
| EP1345950A2 (fr) | 2003-09-24 |
| CA2430190A1 (fr) | 2002-05-30 |
| WO2002041831A3 (fr) | 2002-07-18 |
| EP1345950A4 (fr) | 2005-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001258771A1 (en) | -secretase inhibitors | |
| AU4677399A (en) | Inhibitors of H+K+-ATPase | |
| AU5597300A (en) | In-line bi-directional razor devices | |
| AU2001275822A1 (en) | Multiple-legged walking apparatus | |
| AU2002220241A1 (en) | Parb inhibitors | |
| AU6474400A (en) | Compressor | |
| AU2001278558A1 (en) | Use of co for treating inflammation of upper airways or bronchi | |
| AU2001268750A1 (en) | Flushed-seal respirator | |
| AU2002217808A1 (en) | Inositol derivatives for increasing chloride secretion and inhibiting inflammation | |
| AU4825300A (en) | Methods for inhibiting cutaneous inflammation and hyperpigmentation | |
| AU2001248472A1 (en) | Compounds derived from LA2MO2O9 and their use as ionic conductors | |
| AU2608301A (en) | Methods for inhibiting mastocytosis | |
| AU2001244562A1 (en) | Neovascularization inhibitors | |
| AU3235100A (en) | Prothease inhibitors | |
| AU7053500A (en) | Chymotrypsin-free trypsin | |
| AU2002227925A1 (en) | Human beta-defensin-3 | |
| AU7627601A (en) | Drug-delivery systems | |
| AU2001275723A1 (en) | Bougie | |
| AU3143899A (en) | Cyclooctadepsipeptides and their use for combating endoparasites | |
| AU2002338989A1 (en) | Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives | |
| AU5762899A (en) | Caspase inhibitor | |
| AU2001293666A1 (en) | Anti-wear protection covering and anti-wear protection plate | |
| AU2001228784A1 (en) | Inositol derivatives and their pharmaceutical use | |
| AU2001265200A1 (en) | Footwear having visual fitting apparatus | |
| AU2002228911A1 (en) | Methods for inhibiting pain |